| Date | Title | Description | |
|---|---|---|---|
| 23 Jul 2026 | On P&L | The Company releases the press release related to the first half of 2026 financial results | Download |
| 23 Jul 2026 | On P&L | The Company releases the first half 2026 financial results presentation | Download |
| 06 May 2026 | On P&L | The Company releases the press release related to the first three months of 2026 financial results. | Download |
| 06 May 2026 | On P&L | The Company releases the first three months of 2026 financial results presentation. | Download |
| 25 Feb 2026 | On P&L | The Company releases the press release related to the full year 2025 financial results. | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 26 Feb 2020 | Annual Corporate Governance Report | ROVI releases the 2019 Annual Corporate Governance Report | Download |
| 26 Feb 2020 | Annual Report regarding remuneration of the members of the Board of Directors | ROVI releases the 2019 annual report regarding remuneration of the members of the Board of Directors | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 26 Feb 2019 | Información sobre resultados | ROVI releases the presentation related to the full year 2018 results | Download |
| 26 Feb 2019 | Información sobre resultados | ROVI releases the press release related to the full year 2018 results | Download |
| 15 Feb 2019 | Others on business performance and financial information | ROVI acquires rights to Dexchlorpheniramine Maleate in the Spanish and French markets | Download |
| 09 Jan 2019 | Others on business performance and financial information | ROVI informs about the adquisition of Falithrom® for the German market | Download |
| 08 Jan 2019 | Liquidity contracts and specialists | Liquidity contract: transactions conducted in the fourth quarter of 2018 | Download |